Carley Langleben
Papers
2
Total Citations
23
H-Index
2
About
Carley Langleben is a urologic oncologist whose research centers on improving surgical outcomes for testicular cancer, with a particular focus on retroperitoneal lymph node dissection (RPLND). Her major contributions include pioneering work comparing open versus robotic approaches for primary RPLND in clinical stage II testicular cancer, where her propensity-matched analysis—cited 21 times since 2024—demonstrated the safety and efficacy of minimally invasive techniques. She has also advanced prognostic modeling by investigating lymph node density as a marker for relapse after RPLND, offering a more nuanced tool for risk stratification. With a growing citation impact that underscores the clinical relevance of her work, Langleben is recognized for integrating surgical innovation with evidence-based practice. Her research not only refines treatment paradigms but also enhances patient counseling by clarifying the trade-offs between surgical approaches. For students and researchers, her work exemplifies how rigorous comparative effectiveness studies can guide precision oncology in urologic surgery.
Research Focus
Key Achievements
Top Papers
- 1
- 2